AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like SI-BONE Announces Published Guidance Recommendation For Minimally Invasive SI Joint Fusion From The SI-BONE April 6, 2017 Strike It Rich With These 3 Biotech Stocks That Have Late-Stage Drugs April 10, 2017 Johnson & Johnson Selling LifeScan Unit for $2.1 Billion March 15, 2018
SI-BONE Announces Published Guidance Recommendation For Minimally Invasive SI Joint Fusion From The SI-BONE April 6, 2017
